Glenmark Pharmaceuticals

About:

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company.

Website: http://www.glenmarkpharma.com

Top Investors: True North, Actis, MAPE Advisory Group

Description:

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Total Funding Amount:

$58M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Andheri, Maharashtra, India

Founded Date:

1977-01-01

Contact Email:

GlobalPV(AT)glenmarkpharma.com

Founders:

Gracias Saldanha

Number of Employees:

10001+

Last Funding Date:

2018-08-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai